[{"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-001", "question": "A 14-year-old boy with a history of recurrent epistaxis presents with progressive dyspnea and hemoptysis. Physical examination reveals telangiectasias on the lips and oral mucosa. Pulmonary angiography shows multiple arteriovenous malformations. Genetic testing confirms a mutation in the ENG gene. What is the most appropriate long-term management strategy to prevent recurrent pulmonary complications?", "options": ["Prophylactic coil embolization of all visible AVMs", "Lifelong anticoagulation with warfarin", "Serial transcatheter embolotherapy guided by symptom recurrence", "Surgical lobectomy for affected lung segments", "Observation with annual CT angiography"], "answer": "C", "answer_index": 2, "explanation": "In hereditary hemorrhagic telangiectasia (HHT) due to ENG mutation, pulmonary AVMs are managed with transcatheter embolotherapy, repeated as needed based on symptoms or imaging, as complete eradication is often not feasible and new AVMs can develop. Prophylactic embolization of all AVMs risks unnecessary procedures and complications, while anticoagulation increases bleeding risk without addressing AVMs. Surgical options are reserved for cases unresponsive to embolization.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes a 14-year-old with recurrent epistaxis, dyspnea, hemoptysis, mucocutaneous telangiectasias, multiple pulmonary AVMs, and confirmed ENG mutation—classic for hereditary hemorrhagic telangiectasia (HHT). The question asks for long-term management to prevent recurrent pulmonary complications. Key discriminators: (1) multiple AVMs requiring ongoing surveillance, (2) new lesions can develop over time, (3) complete eradication often unfeasible. Choice C (serial transcatheter embolotherapy guided by symptoms/imaging) aligns with HHT management guidelines: treat symptomatic or high-risk AVMs, monitor for new lesions, repeat intervention as needed. Choice A (prophylactic embolization of all visible AVMs) is overly aggressive, risks complications, and is impractical given ongoing AVM formation. Choice B (anticoagulation) increases bleeding risk in HHT without treating AVMs. Choice D (surgical lobectomy) is too invasive for multifocal disease and reserved for embolization failures. Choice E (observation alone) inadequately addresses symptomatic AVMs causing hemoptysis/dyspnea. The item is logically valid with a unique best answer matching the key. Medical accuracy is high, reflecting current HHT management consensus. Minimal fix: none needed; item is well-constructed.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a 14-year-old with recurrent epistaxis, dyspnea, hemoptysis, mucocutaneous telangiectasias, multiple pulmonary AVMs, and confirmed ENG mutation—classic for hereditary hemorrhagic telangiectasia (HHT). The question asks for long-term management to prevent recurrent pulmonary complications. Key discriminators: (1) multiple AVMs requiring ongoing surveillance, (2) new lesions can develop over time, (3) complete eradication often unfeasible. Choice C (serial transcatheter embolotherapy guided by symptoms/imaging) aligns with HHT management guidelines: treat symptomatic or high-risk AVMs, monitor for new lesions, repeat intervention as needed. Choice A (prophylactic embolization of all visible AVMs) is overly aggressive, risks complications, and is impractical given ongoing AVM formation. Choice B (anticoagulation) increases bleeding risk in HHT without treating AVMs. Choice D (surgical lobectomy) is too invasive for multifocal disease and reserved for embolization failures. Choice E (observation alone) inadequately addresses symptomatic AVMs causing hemoptysis/dyspnea. The item is logically valid with a unique best answer matching the key. Medical accuracy is high, reflecting current HHT management consensus. Minimal fix: none needed; item is well-constructed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-002", "question": "A 6-month-old infant with known tetralogy of Fallot develops sudden cyanosis and agitation during a routine clinic visit. The child is tachypneic with oxygen saturation of 65%. Echocardiography shows severe right ventricular outflow tract obstruction. After initial stabilization with knee-to-chest positioning and morphine, what is the next best pharmacologic intervention to abort the hypercyanotic spell?", "options": ["Intravenous propranolol", "Subcutaneous epinephrine", "Intravenous phenylephrine", "Oral sildenafil", "Intravenous esmolol"], "answer": "C", "answer_index": 2, "explanation": "Phenylephrine increases systemic vascular resistance, reducing right-to-left shunting in tetralogy of Fallot during a hypercyanotic spell. Propranolol or esmolol may be used but are not first-line for acute spells; epinephrine could worsen infundibular spasm. Sildenafil is not indicated acutely for this scenario.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a classic hypercyanotic (\\\"tet\\\") spell in an infant with tetralogy of Fallot: sudden cyanosis, agitation, tachypnea, severe hypoxemia (SpO2 65%), and RVOT obstruction. After initial non-pharmacologic measures (knee-chest, morphine), the question asks for the next best pharmacologic intervention. Key discriminating clue: need to acutely reduce right-to-left shunting by increasing systemic vascular resistance (SVR). Phenylephrine (C) is a pure alpha-agonist that rapidly increases SVR, thereby increasing afterload and reducing the shunt across the VSD, which is the established acute pharmacologic treatment for refractory tet spells. Propranolol (A) and esmolol (E) are beta-blockers that may prevent spells or treat tachycardia/infundibular spasm but are not first-line for acute spell abortion when SVR augmentation is needed. Epinephrine (B) has beta-agonist effects that can worsen infundibular spasm and tachycardia. Sildenafil (D) is a pulmonary vasodilator with no role in acute tet spell management. The keyed answer aligns with standard pediatric cardiology practice. No logical flaws or medical inaccuracies detected. Minimal fix: None needed; item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a classic hypercyanotic (\"tet\") spell in an infant with tetralogy of Fallot: sudden cyanosis, agitation, tachypnea, severe hypoxemia (SpO2 65%), and RVOT obstruction. After initial non-pharmacologic measures (knee-chest, morphine), the question asks for the next best pharmacologic intervention. Key discriminating clue: need to acutely reduce right-to-left shunting by increasing systemic vascular resistance (SVR). Phenylephrine (C) is a pure alpha-agonist that rapidly increases SVR, thereby increasing afterload and reducing the shunt across the VSD, which is the established acute pharmacologic treatment for refractory tet spells. Propranolol (A) and esmolol (E) are beta-blockers that may prevent spells or treat tachycardia/infundibular spasm but are not first-line for acute spell abortion when SVR augmentation is needed. Epinephrine (B) has beta-agonist effects that can worsen infundibular spasm and tachycardia. Sildenafil (D) is a pulmonary vasodilator with no role in acute tet spell management. The keyed answer aligns with standard pediatric cardiology practice. No logical flaws or medical inaccuracies detected. Minimal fix: None needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-003", "question": "A 9-year-old girl with neurofibromatosis type 1 presents with hypertension and headaches. MRI reveals a pheochromocytoma and bilateral renal artery stenosis. Genetic analysis confirms NF1 mutation. What is the most appropriate initial management for her hypertension prior to surgical intervention?", "options": ["Alpha-blockade with phenoxybenzamine followed by beta-blockade", "Angiotensin-converting enzyme inhibitor monotherapy", "Percutaneous renal artery angioplasty", "Calcium channel blocker initiation", "Surgical resection of pheochromocytoma without preoperative preparation"], "answer": "A", "answer_index": 0, "explanation": "In pheochromocytoma associated with NF1, preoperative alpha-blockade followed by beta-blockade is essential to prevent hypertensive crisis during surgery. ACE inhibitors may exacerbate renal stenosis issues, and angioplasty or surgery without preparation risks catecholamine surge. Calcium channel blockers are not sufficient alone.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 9-year-old with NF1, pheochromocytoma, and bilateral renal artery stenosis presenting with hypertension. The question explicitly asks for initial management \\\"prior to surgical intervention,\\\" making this a preoperative preparation question. Key discriminating findings: confirmed pheochromocytoma (catecholamine-secreting tumor) requiring surgery. Standard preoperative management for pheochromocytoma mandates alpha-blockade (phenoxybenzamine) followed by beta-blockade to prevent intraoperative hypertensive crisis and arrhythmias from catecholamine surge. Option A correctly identifies this protocol. Option B (ACE inhibitor) addresses renovascular hypertension but ignores the pheochromocytoma, which is the immediate surgical priority requiring preoperative preparation. Option C (angioplasty) is a procedural intervention, not medical management, and doesn't address pheochromocytoma preparation. Option D (calcium channel blocker) lacks sufficient catecholamine blockade for safe surgery. Option E explicitly contradicts safe practice by omitting preoperative preparation. The presence of bilateral renal artery stenosis adds complexity but doesn't change the immediate need for pheochromocytoma preparation before any surgical intervention. Medical accuracy: fully consistent with standard perioperative pheochromocytoma management guidelines. No logical flaws or ambiguity. Minimal fix: none needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 9-year-old with NF1, pheochromocytoma, and bilateral renal artery stenosis presenting with hypertension. The question explicitly asks for initial management \"prior to surgical intervention,\" making this a preoperative preparation question. Key discriminating findings: confirmed pheochromocytoma (catecholamine-secreting tumor) requiring surgery. Standard preoperative management for pheochromocytoma mandates alpha-blockade (phenoxybenzamine) followed by beta-blockade to prevent intraoperative hypertensive crisis and arrhythmias from catecholamine surge. Option A correctly identifies this protocol. Option B (ACE inhibitor) addresses renovascular hypertension but ignores the pheochromocytoma, which is the immediate surgical priority requiring preoperative preparation. Option C (angioplasty) is a procedural intervention, not medical management, and doesn't address pheochromocytoma preparation. Option D (calcium channel blocker) lacks sufficient catecholamine blockade for safe surgery. Option E explicitly contradicts safe practice by omitting preoperative preparation. The presence of bilateral renal artery stenosis adds complexity but doesn't change the immediate need for pheochromocytoma preparation before any surgical intervention. Medical accuracy: fully consistent with standard perioperative pheochromocytoma management guidelines. No logical flaws or ambiguity. Minimal fix: none needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-004", "question": "A neonate with congenital diaphragmatic hernia undergoes surgical repair at 48 hours of life. Postoperatively, the infant develops persistent pulmonary hypertension with right-to-left shunting on echocardiography. Despite maximal ventilatory support and inhaled nitric oxide, oxygenation remains poor. What is the most appropriate next step in management?", "options": ["Initiation of extracorporeal membrane oxygenation", "Administration of intravenous milrinone", "High-frequency oscillatory ventilation trial", "Surgical revision of hernia repair", "Prostaglandin E1 infusion"], "answer": "A", "answer_index": 0, "explanation": "ECMO is indicated for refractory pulmonary hypertension in congenital diaphragmatic hernia when conventional therapies fail. Milrinone may help but is not superior to ECMO in severe cases; HFOV is already part of maximal support. Surgical revision or PGE1 is not appropriate without evidence of ductal dependency.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a neonate post-CDH repair with refractory persistent pulmonary hypertension (PPHN) and right-to-left shunting despite maximal ventilatory support and inhaled nitric oxide. Key discriminating findings: (1) severe PPHN refractory to conventional therapy, (2) poor oxygenation despite maximal support including iNO, (3) post-CDH repair context. The clinical problem asks for next management when standard therapies have failed. Option A (ECMO) is the established rescue therapy for refractory PPHN in CDH when conventional management fails—this is well-supported by guidelines and represents standard of care. Option B (milrinone) is an inotrope/vasodilator that may help but is insufficient as monotherapy in this severe scenario. Option C (HFOV) is reasonably considered part of 'maximal ventilatory support' already tried. Option D (surgical revision) addresses only anatomic issues, not the primary pulmonary vascular pathology. Option E (PGE1) maintains ductal patency but the stem provides no evidence of ductal-dependent systemic circulation requiring this intervention. The keyed answer is medically accurate and uniquely defensible. No logical flaws present. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a neonate post-CDH repair with refractory persistent pulmonary hypertension (PPHN) and right-to-left shunting despite maximal ventilatory support and inhaled nitric oxide. Key discriminating findings: (1) severe PPHN refractory to conventional therapy, (2) poor oxygenation despite maximal support including iNO, (3) post-CDH repair context. The clinical problem asks for next management when standard therapies have failed. Option A (ECMO) is the established rescue therapy for refractory PPHN in CDH when conventional management fails—this is well-supported by guidelines and represents standard of care. Option B (milrinone) is an inotrope/vasodilator that may help but is insufficient as monotherapy in this severe scenario. Option C (HFOV) is reasonably considered part of 'maximal ventilatory support' already tried. Option D (surgical revision) addresses only anatomic issues, not the primary pulmonary vascular pathology. Option E (PGE1) maintains ductal patency but the stem provides no evidence of ductal-dependent systemic circulation requiring this intervention. The keyed answer is medically accurate and uniquely defensible. No logical flaws present. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-005", "question": "A 32-year-old woman at 28 weeks gestation with a history of antiphospholipid syndrome presents with severe preeclampsia. Laboratory evaluation shows thrombocytopenia, elevated liver enzymes, and hemolysis. Fetal monitoring indicates non-reassuring heart rate patterns. What is the most appropriate immediate management?", "options": ["Expectant management with close monitoring", "Immediate delivery via cesarean section", "Administration of intravenous magnesium sulfate alone", "Plasma exchange therapy", "High-dose corticosteroid initiation"], "answer": "B", "answer_index": 1, "explanation": "In HELLP syndrome superimposed on preeclampsia in antiphospholipid syndrome, immediate delivery is indicated at 28 weeks due to maternal and fetal risks. Expectant management is not suitable beyond 34 weeks or with severe features; magnesium prevents seizures but does not address the need for delivery. Plasma exchange and steroids are not first-line.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes a 28-week pregnant woman with antiphospholipid syndrome presenting with severe preeclampsia plus laboratory triad (thrombocytopenia, elevated liver enzymes, hemolysis) consistent with HELLP syndrome, compounded by non-reassuring fetal heart rate patterns. Key discriminating findings: (1) severe preeclampsia with HELLP at 28 weeks, (2) non-reassuring fetal status, (3) underlying thrombophilic disorder. The combination of maternal HELLP syndrome with severe features plus fetal compromise mandates immediate delivery regardless of gestational age. Option B (immediate cesarean delivery) is correct: non-reassuring fetal heart rate patterns indicate fetal distress requiring emergent delivery, and cesarean is appropriate given urgency. Option A is contraindicated with severe features and fetal compromise. Option C (magnesium alone) addresses seizure prophylaxis but ignores the delivery imperative. Options D and E are not standard acute management for HELLP. The keyed answer aligns with ACOG guidelines: delivery is definitive treatment for HELLP with severe features, especially with fetal compromise. Medical accuracy is high; the clinical scenario clearly supports immediate delivery. No logical ambiguity exists. Minimal fix: none needed; item is valid and accurate.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a 28-week pregnant woman with antiphospholipid syndrome presenting with severe preeclampsia plus laboratory triad (thrombocytopenia, elevated liver enzymes, hemolysis) consistent with HELLP syndrome, compounded by non-reassuring fetal heart rate patterns. Key discriminating findings: (1) severe preeclampsia with HELLP at 28 weeks, (2) non-reassuring fetal status, (3) underlying thrombophilic disorder. The combination of maternal HELLP syndrome with severe features plus fetal compromise mandates immediate delivery regardless of gestational age. Option B (immediate cesarean delivery) is correct: non-reassuring fetal heart rate patterns indicate fetal distress requiring emergent delivery, and cesarean is appropriate given urgency. Option A is contraindicated with severe features and fetal compromise. Option C (magnesium alone) addresses seizure prophylaxis but ignores the delivery imperative. Options D and E are not standard acute management for HELLP. The keyed answer aligns with ACOG guidelines: delivery is definitive treatment for HELLP with severe features, especially with fetal compromise. Medical accuracy is high; the clinical scenario clearly supports immediate delivery. No logical ambiguity exists. Minimal fix: none needed; item is valid and accurate.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-006", "question": "A 28-year-old primigravida at 36 weeks gestation presents with vaginal bleeding and abdominal pain. Ultrasound reveals placental abruption with fetal bradycardia. Coagulation studies show prolonged PT and PTT, low fibrinogen, and elevated D-dimer. What is the most critical initial intervention?", "options": ["Immediate cesarean delivery under general anesthesia", "Transfusion of fresh frozen plasma and cryoprecipitate", "Administration of recombinant factor VIIa", "Expectant management with tocolysis", "Intrauterine balloon tamponade"], "answer": "B", "answer_index": 1, "explanation": "Abruption with disseminated intravascular coagulation requires urgent correction of coagulopathy with FFP and cryoprecipitate to enable safe delivery. Immediate cesarean without addressing DIC risks massive hemorrhage; factor VIIa is reserved for refractory cases. Expectant management or tamponade is inappropriate with fetal compromise.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed – A is the correct best answer, not B. The stem describes placental abruption with fetal bradycardia (fetal compromise) and maternal DIC at 36 weeks. Key discriminating findings: (1) fetal bradycardia indicating imminent fetal demise, (2) coagulopathy (DIC), (3) viable gestational age. The clinical problem is prioritizing immediate delivery versus coagulopathy correction. In obstetric emergencies with fetal bradycardia from abruption, immediate cesarean delivery (A) takes priority – decision-to-delivery should be <30 minutes, ideally <10 minutes for category-1 urgency. While the coagulopathy is severe, delaying for transfusion risks fetal death. Standard practice is simultaneous preparation: rush to OR while mobilizing blood products, with transfusion occurring intraoperatively/perioperatively. The keyed answer (B) incorrectly prioritizes transfusion first, which delays life-saving delivery. Factor VIIa (C) is indeed reserved for refractory bleeding. Expectant management (D) and tamponade (E) are contraindicated with fetal compromise. Medical accuracy issue: the rationale conflates 'addressing DIC before surgery' with optimal management; in reality, emergent delivery proceeds concurrently with resuscitation. Minimal fix: Change key to A, or reframe stem to remove fetal bradycardia (making coagulopathy correction the priority before semi-urgent delivery).\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed – A is the correct best answer, not B. The stem describes placental abruption with fetal bradycardia (fetal compromise) and maternal DIC at 36 weeks. Key discriminating findings: (1) fetal bradycardia indicating imminent fetal demise, (2) coagulopathy (DIC), (3) viable gestational age. The clinical problem is prioritizing immediate delivery versus coagulopathy correction. In obstetric emergencies with fetal bradycardia from abruption, immediate cesarean delivery (A) takes priority – decision-to-delivery should be <30 minutes, ideally <10 minutes for category-1 urgency. While the coagulopathy is severe, delaying for transfusion risks fetal death. Standard practice is simultaneous preparation: rush to OR while mobilizing blood products, with transfusion occurring intraoperatively/perioperatively. The keyed answer (B) incorrectly prioritizes transfusion first, which delays life-saving delivery. Factor VIIa (C) is indeed reserved for refractory bleeding. Expectant management (D) and tamponade (E) are contraindicated with fetal compromise. Medical accuracy issue: the rationale conflates 'addressing DIC before surgery' with optimal management; in reality, emergent delivery proceeds concurrently with resuscitation. Minimal fix: Change key to A, or reframe stem to remove fetal bradycardia (making coagulopathy correction the priority before semi-urgent delivery).", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-007", "question": "A 40-year-old woman with a history of endometriosis undergoes laparoscopic hysterectomy. Intraoperatively, she develops sudden hypotension, tachycardia, and increased end-tidal CO2. Arterial blood gas shows respiratory acidosis. What is the most likely diagnosis, and what is the immediate management?", "options": ["Venous air embolism; hyperventilation and left lateral positioning", "CO2 embolism; increase insufflation pressure", "Anaphylaxis to latex; epinephrine administration", "Hemorrhagic shock; fluid resuscitation", "Malignant hyperthermia; dantrolene infusion"], "answer": "A", "answer_index": 0, "explanation": "CO2 embolism during laparoscopy presents with hypotension, tachycardia, and elevated ETCO2; management includes hyperventilation, left lateral positioning, and aspiration if possible. Increasing pressure worsens embolism; anaphylaxis lacks ETCO2 rise. Hemorrhage or hyperthermia have different presentations.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: The keyed answer is incorrect; the correct answer is not provided. Key stem clues: laparoscopic hysterectomy (CO2 pneumoperitoneum), sudden hypotension, tachycardia, increased ETCO2, and respiratory acidosis. These findings are pathognomonic for CO2 embolism during laparoscopy. CO2 embolism occurs when insufflation gas enters venous circulation, causing increased ETCO2 (CO2 is absorbed), hypotension, and tachycardia. Management includes stopping insufflation, hyperventilation, left lateral decubitus positioning (Durant maneuver), and aspiration via central line if available. Option A states 'venous air embolism' but air embolism would cause decreased ETCO2 (air is not absorbed like CO2). The rationale correctly describes CO2 embolism but labels it as answer A (venous air embolism). Option B mentions CO2 embolism but incorrectly suggests increasing insufflation pressure, which would worsen the condition. The item appears to have a labeling error where the correct pathophysiology (CO2 embolism) is split between option A's management and option B's diagnosis. Minimal fix: Rewrite option A as 'CO2 embolism; hyperventilation and left lateral positioning' or create a new option combining the correct diagnosis with correct management.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: The keyed answer is incorrect; the correct answer is not provided. Key stem clues: laparoscopic hysterectomy (CO2 pneumoperitoneum), sudden hypotension, tachycardia, increased ETCO2, and respiratory acidosis. These findings are pathognomonic for CO2 embolism during laparoscopy. CO2 embolism occurs when insufflation gas enters venous circulation, causing increased ETCO2 (CO2 is absorbed), hypotension, and tachycardia. Management includes stopping insufflation, hyperventilation, left lateral decubitus positioning (Durant maneuver), and aspiration via central line if available. Option A states 'venous air embolism' but air embolism would cause decreased ETCO2 (air is not absorbed like CO2). The rationale correctly describes CO2 embolism but labels it as answer A (venous air embolism). Option B mentions CO2 embolism but incorrectly suggests increasing insufflation pressure, which would worsen the condition. The item appears to have a labeling error where the correct pathophysiology (CO2 embolism) is split between option A's management and option B's diagnosis. Minimal fix: Rewrite option A as 'CO2 embolism; hyperventilation and left lateral positioning' or create a new option combining the correct diagnosis with correct management.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-008", "question": "A 55-year-old man undergoing coronary artery bypass grafting develops refractory hypotension post-cardiopulmonary bypass. Echocardiography shows right ventricular dilation and septal shift. Pulmonary artery catheter reveals elevated pulmonary artery pressures. What is the most appropriate pharmacologic intervention?", "options": ["Inhaled nitric oxide", "Intravenous dobutamine", "Milrinone infusion", "Norepinephrine bolus", "Vasopressin drip"], "answer": "A", "answer_index": 0, "explanation": "Prototypical right ventricular failure post-CABG with pulmonary hypertension responds best to inhaled nitric oxide as a selective pulmonary vasodilator. Dobutamine and milrinone may help inotropy but not selectively reduce PVR; norepinephrine and vasopressin are systemic vasopressors without pulmonary specificity.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. The stem describes post-cardiopulmonary bypass refractory hypotension with echocardiographic findings of RV dilation and septal shift (indicating RV pressure/volume overload) plus elevated pulmonary artery pressures on PA catheter—classic for acute RV failure secondary to pulmonary hypertension. Key discriminating findings: (1) post-CPB setting (known risk for pulmonary hypertension), (2) RV dilation with septal shift (RV strain pattern), (3) elevated PA pressures, (4) refractory hypotension. The clinical problem is acute RV failure driven by elevated pulmonary vascular resistance. Inhaled nitric oxide (A) is the gold-standard selective pulmonary vasodilator that reduces PVR without systemic hypotension, directly addressing the pathophysiology. Dobutamine (B) and milrinone (C) provide inotropic support and some pulmonary vasodilation but lack the selective pulmonary specificity and potency of iNO in this acute setting. Norepinephrine (D) and vasopressin (E) are systemic vasopressors that may worsen RV afterload by increasing PVR. The keyed answer is medically accurate and uniquely best. No logical flaws; all necessary details present. Minimal fix: None needed; item is valid and accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes post-cardiopulmonary bypass refractory hypotension with echocardiographic findings of RV dilation and septal shift (indicating RV pressure/volume overload) plus elevated pulmonary artery pressures on PA catheter—classic for acute RV failure secondary to pulmonary hypertension. Key discriminating findings: (1) post-CPB setting (known risk for pulmonary hypertension), (2) RV dilation with septal shift (RV strain pattern), (3) elevated PA pressures, (4) refractory hypotension. The clinical problem is acute RV failure driven by elevated pulmonary vascular resistance. Inhaled nitric oxide (A) is the gold-standard selective pulmonary vasodilator that reduces PVR without systemic hypotension, directly addressing the pathophysiology. Dobutamine (B) and milrinone (C) provide inotropic support and some pulmonary vasodilation but lack the selective pulmonary specificity and potency of iNO in this acute setting. Norepinephrine (D) and vasopressin (E) are systemic vasopressors that may worsen RV afterload by increasing PVR. The keyed answer is medically accurate and uniquely best. No logical flaws; all necessary details present. Minimal fix: None needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-009", "question": "A 70-year-old woman with chronic obstructive pulmonary disease is intubated for type II respiratory failure during total hip replacement. Post-extubation, she develops stridor and respiratory distress. Laryngoscopy reveals bilateral vocal cord paralysis. What is the most likely etiology, and what is the definitive management?", "options": ["Arytenoid dislocation from intubation; surgical repositioning", "Recurrent laryngeal nerve injury; tracheostomy", "Hypocalcemia-induced spasm; calcium gluconate", "Anesthetic-induced neuropathy; observation", "Allergic reaction; steroids and antihistamines"], "answer": "A", "answer_index": 0, "explanation": "Arytenoid dislocation is a rare complication of intubation causing vocal cord immobility; management involves endoscopic or surgical repositioning. Nerve injury typically presents unilaterally; hypocalcemia is unlikely without parathyroid involvement. Neuropathy or allergy do not fit the acute bilateral presentation.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed – the keyed answer is not the best answer. The stem describes bilateral vocal cord paralysis post-extubation after intubation. Key discriminating findings: 70-year-old, COPD, intubated for type II respiratory failure, post-extubation stridor and respiratory distress, laryngoscopy confirms bilateral vocal cord paralysis. The question asks for most likely etiology AND definitive management. Arytenoid dislocation (option A) typically causes unilateral vocal cord immobility, not bilateral paralysis as stated. Bilateral recurrent laryngeal nerve (RLN) injury from intubation trauma or endotracheal tube cuff pressure is the more likely etiology for true bilateral vocal cord paralysis. Definitive management for bilateral vocal cord paralysis causing airway obstruction is tracheostomy (option B), not surgical repositioning. The author rationale incorrectly states nerve injury presents unilaterally, but bilateral RLN injury, though rare, does occur with intubation and causes bilateral paralysis. Main logical issue: the keyed answer does not match the clinical presentation of bilateral paralysis. Main medical accuracy issue: arytenoid dislocation does not typically cause bilateral paralysis; bilateral RLN injury is the correct etiology. Minimal fix: change the correct answer key to B, or rewrite the stem to describe unilateral vocal cord immobility if A is intended.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed – the keyed answer is not the best answer. The stem describes bilateral vocal cord paralysis post-extubation after intubation. Key discriminating findings: 70-year-old, COPD, intubated for type II respiratory failure, post-extubation stridor and respiratory distress, laryngoscopy confirms bilateral vocal cord paralysis. The question asks for most likely etiology AND definitive management. Arytenoid dislocation (option A) typically causes unilateral vocal cord immobility, not bilateral paralysis as stated. Bilateral recurrent laryngeal nerve (RLN) injury from intubation trauma or endotracheal tube cuff pressure is the more likely etiology for true bilateral vocal cord paralysis. Definitive management for bilateral vocal cord paralysis causing airway obstruction is tracheostomy (option B), not surgical repositioning. The author rationale incorrectly states nerve injury presents unilaterally, but bilateral RLN injury, though rare, does occur with intubation and causes bilateral paralysis. Main logical issue: the keyed answer does not match the clinical presentation of bilateral paralysis. Main medical accuracy issue: arytenoid dislocation does not typically cause bilateral paralysis; bilateral RLN injury is the correct etiology. Minimal fix: change the correct answer key to B, or rewrite the stem to describe unilateral vocal cord immobility if A is intended.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-010", "question": "A 45-year-old man with treatment-resistant depression and a history of electroconvulsive therapy presents with catatonia, mutism, and waxy flexibility. He has not responded to lorazepam. What is the most appropriate next step in management?", "options": ["Bilateral electroconvulsive therapy", "Intravenous amobarbital challenge", "High-dose olanzapine initiation", "Repetitive transcranial magnetic stimulation", "Ketamine infusion trial"], "answer": "A", "answer_index": 0, "explanation": "ECT is the treatment of choice for catatonia unresponsive to benzodiazepines, with high efficacy in psychiatric emergencies. Amobarbital is outdated and not standard; olanzapine may help but is not first-line for refractory cases. rTMS and ketamine lack strong evidence for acute catatonia.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 45-year-old man with treatment-resistant depression, prior ECT history, presenting with classic catatonia features (mutism, waxy flexibility) unresponsive to lorazepam. The clinical problem is identifying the next management step for benzodiazepine-refractory catatonia. Key discriminating findings: (1) catatonia with classic signs, (2) lorazepam failure, (3) psychiatric emergency requiring definitive treatment. ECT (option A) is the established gold-standard treatment for benzodiazepine-refractory catatonia, with response rates of 80-100% and rapid efficacy. The keyed answer is strongly supported by current guidelines (APA, WFSBP). Alternative assessment: (B) Amobarbital challenge is largely historical, rarely used, and not standard care. (C) High-dose olanzapine lacks robust evidence for acute refractory catatonia. (D) rTMS has insufficient evidence for catatonia treatment. (E) Ketamine shows emerging interest but lacks established efficacy data for catatonia compared to ECT. No logical issues present; stem provides sufficient detail for unique best answer. Medical accuracy is excellent, reflecting current standard of care. Minimal fix: None needed; item is valid and accurate as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 45-year-old man with treatment-resistant depression, prior ECT history, presenting with classic catatonia features (mutism, waxy flexibility) unresponsive to lorazepam. The clinical problem is identifying the next management step for benzodiazepine-refractory catatonia. Key discriminating findings: (1) catatonia with classic signs, (2) lorazepam failure, (3) psychiatric emergency requiring definitive treatment. ECT (option A) is the established gold-standard treatment for benzodiazepine-refractory catatonia, with response rates of 80-100% and rapid efficacy. The keyed answer is strongly supported by current guidelines (APA, WFSBP). Alternative assessment: (B) Amobarbital challenge is largely historical, rarely used, and not standard care. (C) High-dose olanzapine lacks robust evidence for acute refractory catatonia. (D) rTMS has insufficient evidence for catatonia treatment. (E) Ketamine shows emerging interest but lacks established efficacy data for catatonia compared to ECT. No logical issues present; stem provides sufficient detail for unique best answer. Medical accuracy is excellent, reflecting current standard of care. Minimal fix: None needed; item is valid and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-011", "question": "A 2-year-old boy with hypoplastic left heart syndrome post-Norwood procedure presents with feeding intolerance and metabolic acidosis. Echocardiography shows preserved ventricular function but elevated right atrial pressure. Cardiac catheterization reveals stenosis at the neo-aortic arch. What is the most appropriate intervention?", "options": ["Balloon angioplasty of the arch stenosis", "Surgical arch augmentation", "Fontan completion procedure", "Heart transplantation evaluation", "Medical management with afterload reduction"], "answer": "B", "answer_index": 1, "explanation": "Surgical augmentation is preferred for neo-aortic arch stenosis in HLHS post-Norwood due to better long-term patency than balloon angioplasty, which has high restenosis rates. Fontan is premature; transplantation is for end-stage failure. Medical management does not address the anatomic issue.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 2-year-old post-Norwood (stage 1 palliation for HLHS) presenting with feeding intolerance, metabolic acidosis, elevated right atrial pressure, and catheterization-confirmed neo-aortic arch stenosis. Key discriminating findings: symptomatic arch obstruction causing systemic ventricular afterload mismatch and end-organ hypoperfusion (feeding intolerance, acidosis). The clinical problem is: what intervention addresses neo-aortic arch stenosis in this post-Norwood patient? Option B (surgical arch augmentation) is the established standard for significant arch obstruction in HLHS post-Norwood, offering superior durability compared to balloon angioplasty (A), which has high restenosis rates in neonatal/infant reconstructed arches. Option C (Fontan) is premature—patients require Glenn/bidirectional cavopulmonary connection before Fontan, typically at 4-6 months and 2-4 years respectively. Option D (transplantation) is reserved for end-stage failure, not isolated arch stenosis with preserved ventricular function. Option E (medical management) cannot resolve anatomic obstruction. The keyed answer aligns with pediatric cardiac surgical consensus. No logical flaws; all alternatives are clearly inferior. Minimal fix: none needed—item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 2-year-old post-Norwood (stage 1 palliation for HLHS) presenting with feeding intolerance, metabolic acidosis, elevated right atrial pressure, and catheterization-confirmed neo-aortic arch stenosis. Key discriminating findings: symptomatic arch obstruction causing systemic ventricular afterload mismatch and end-organ hypoperfusion (feeding intolerance, acidosis). The clinical problem is: what intervention addresses neo-aortic arch stenosis in this post-Norwood patient? Option B (surgical arch augmentation) is the established standard for significant arch obstruction in HLHS post-Norwood, offering superior durability compared to balloon angioplasty (A), which has high restenosis rates in neonatal/infant reconstructed arches. Option C (Fontan) is premature—patients require Glenn/bidirectional cavopulmonary connection before Fontan, typically at 4-6 months and 2-4 years respectively. Option D (transplantation) is reserved for end-stage failure, not isolated arch stenosis with preserved ventricular function. Option E (medical management) cannot resolve anatomic obstruction. The keyed answer aligns with pediatric cardiac surgical consensus. No logical flaws; all alternatives are clearly inferior. Minimal fix: none needed—item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-012", "question": "A 10-year-old girl with sickle cell disease presents with acute chest syndrome, fever, and hypoxia. Chest X-ray shows multilobar infiltrates. She is on hydroxyurea and has received pneumococcal vaccines. What is the most appropriate additional therapy to reduce morbidity?", "options": ["Exchange transfusion", "Intravenous ceftriaxone monotherapy", "High-dose corticosteroids", "Inhaled nitric oxide", "Therapeutic anticoagulation"], "answer": "A", "answer_index": 0, "explanation": "Exchange transfusion is indicated for severe acute chest syndrome in sickle cell disease to reduce sickle hemoglobin and improve oxygenation. Antibiotics address infection but not vaso-occlusion; steroids are controversial and risk rebound. Nitric oxide and anticoagulation lack evidence in this context.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 10-year-old with sickle cell disease presenting with severe acute chest syndrome (ACS) characterized by multilobar infiltrates, fever, and hypoxia. Key discriminating findings include the severity markers (multilobar involvement, hypoxia) that distinguish this from mild ACS. The question asks for \\\"most appropriate additional therapy to reduce morbidity,\\\" implying antibiotics are already standard. Exchange transfusion (A) is the established intervention for severe ACS, rapidly reducing HbS percentage and improving oxygen delivery while removing sickled cells. Option B (ceftriaxone monotherapy) addresses infection but doesn't treat the underlying vaso-occlusive crisis driving severe ACS. Option C (corticosteroids) has controversial evidence with rebound pain risk. Options D and E lack supporting evidence in ACS management. The keyed answer aligns with current guidelines (NHLBI, ASH) recommending exchange transfusion for severe ACS with multilobar disease or significant hypoxia. Medical accuracy is high; the item correctly identifies exchange transfusion as standard of care for severe ACS. The stem provides sufficient severity markers to justify exchange transfusion over antibiotics alone. Minimal fix: None needed; item is logically valid and medically accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 10-year-old with sickle cell disease presenting with severe acute chest syndrome (ACS) characterized by multilobar infiltrates, fever, and hypoxia. Key discriminating findings include the severity markers (multilobar involvement, hypoxia) that distinguish this from mild ACS. The question asks for \"most appropriate additional therapy to reduce morbidity,\" implying antibiotics are already standard. Exchange transfusion (A) is the established intervention for severe ACS, rapidly reducing HbS percentage and improving oxygen delivery while removing sickled cells. Option B (ceftriaxone monotherapy) addresses infection but doesn't treat the underlying vaso-occlusive crisis driving severe ACS. Option C (corticosteroids) has controversial evidence with rebound pain risk. Options D and E lack supporting evidence in ACS management. The keyed answer aligns with current guidelines (NHLBI, ASH) recommending exchange transfusion for severe ACS with multilobar disease or significant hypoxia. Medical accuracy is high; the item correctly identifies exchange transfusion as standard of care for severe ACS. The stem provides sufficient severity markers to justify exchange transfusion over antibiotics alone. Minimal fix: None needed; item is logically valid and medically accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-013", "question": "A 5-year-old boy with ataxia-telangiectasia develops progressive dysphagia and recurrent aspiration pneumonia. Genetic testing confirms ATM mutation. Videofluoroscopic swallow study shows pharyngeal dysmotility. What is the most appropriate long-term management to prevent pulmonary complications?", "options": ["Gastrostomy tube placement for enteral feeding", "Speech therapy with thickened liquids", "Botulinum toxin injection into cricopharyngeus", "Esophageal dilation procedure", "Prokinetic agent administration"], "answer": "A", "answer_index": 0, "explanation": "In ataxia-telangiectasia with severe dysphagia, gastrostomy tube bypasses aspiration risk and ensures nutrition, as the neurologic deficit is progressive. Speech therapy may help mildly but not prevent recurrent pneumonia; botox or dilation address specific issues not present here. Prokinetics do not resolve dysmotility.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 5-year-old with ataxia-telangiectasia (confirmed ATM mutation) presenting with progressive dysphagia, recurrent aspiration pneumonia, and videofluoroscopic evidence of pharyngeal dysmotility. The question asks for long-term management to prevent pulmonary complications. Key discriminating findings: (1) progressive neurologic disease, (2) recurrent aspiration pneumonia, (3) pharyngeal dysmotility on objective testing. In ataxia-telangiectasia, neurologic deterioration is progressive and irreversible. Gastrostomy tube (A) bypasses the oropharyngeal phase entirely, eliminating aspiration risk while ensuring adequate nutrition—the definitive solution for progressive dysphagia with recurrent aspiration. Speech therapy with thickened liquids (B) may help mild dysphagia but cannot prevent aspiration in progressive pharyngeal dysmotility. Botulinum toxin (C) treats cricopharyngeal achalasia/spasm, not demonstrated here. Esophageal dilation (D) addresses esophageal strictures, irrelevant to pharyngeal dysmotility. Prokinetics (E) target esophageal/gastric motility, not oropharyngeal dysfunction. The keyed answer is medically sound and uniquely best. No logical flaws or medical inaccuracies present. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 5-year-old with ataxia-telangiectasia (confirmed ATM mutation) presenting with progressive dysphagia, recurrent aspiration pneumonia, and videofluoroscopic evidence of pharyngeal dysmotility. The question asks for long-term management to prevent pulmonary complications. Key discriminating findings: (1) progressive neurologic disease, (2) recurrent aspiration pneumonia, (3) pharyngeal dysmotility on objective testing. In ataxia-telangiectasia, neurologic deterioration is progressive and irreversible. Gastrostomy tube (A) bypasses the oropharyngeal phase entirely, eliminating aspiration risk while ensuring adequate nutrition—the definitive solution for progressive dysphagia with recurrent aspiration. Speech therapy with thickened liquids (B) may help mild dysphagia but cannot prevent aspiration in progressive pharyngeal dysmotility. Botulinum toxin (C) treats cricopharyngeal achalasia/spasm, not demonstrated here. Esophageal dilation (D) addresses esophageal strictures, irrelevant to pharyngeal dysmotility. Prokinetics (E) target esophageal/gastric motility, not oropharyngeal dysfunction. The keyed answer is medically sound and uniquely best. No logical flaws or medical inaccuracies present. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-014", "question": "A neonate with trisomy 21 presents with bilious vomiting and abdominal distension. X-ray shows double bubble sign. Echocardiography reveals an atrioventricular septal defect. What is the most appropriate preoperative management prior to duodenal atresia repair?", "options": ["Cardiac catheterization for defect assessment", "Prostaglandin infusion to maintain ductal patency", "Nasogastric decompression and parenteral nutrition", "Immediate surgical repair without delay", "Antibiotic prophylaxis for endocarditis"], "answer": "C", "answer_index": 2, "explanation": "Duodenal atresia in Down syndrome requires NG decompression and TPN to stabilize before surgery, allowing time for cardiac evaluation. Catheterization is invasive and not routine; PGE is for ductal-dependent lesions. Immediate repair risks instability; prophylaxis is perioperative.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes a neonate with trisomy 21, bilious vomiting, abdominal distension, and double bubble sign (classic for duodenal atresia), plus an AVSD on echo. The question asks for most appropriate preoperative management before duodenal atresia repair. Key discriminating findings: bilious vomiting/distension require gastric decompression; neonate needs metabolic stabilization; AVSD is present but not ductal-dependent. Choice C (NG decompression + parenteral nutrition) is the standard preoperative stabilization for duodenal atresia—prevents aspiration, corrects fluid/electrolyte imbalances, allows cardiac workup. Choice A (cardiac cath) is invasive, not routine preop for AVSD. Choice B (PGE) is for ductal-dependent lesions (coarctation, critical AS/PS); AVSD is not ductal-dependent. Choice D (immediate repair) ignores need for stabilization and cardiac assessment. Choice E (endocarditis prophylaxis) is perioperative, not the primary preop management. Medical accuracy: fully consistent with neonatal surgery standards—duodenal atresia requires decompression/stabilization before repair, especially with cardiac anomalies. No logical flaws; single best answer clearly supported. Minimal fix: none needed; item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a neonate with trisomy 21, bilious vomiting, abdominal distension, and double bubble sign (classic for duodenal atresia), plus an AVSD on echo. The question asks for most appropriate preoperative management before duodenal atresia repair. Key discriminating findings: bilious vomiting/distension require gastric decompression; neonate needs metabolic stabilization; AVSD is present but not ductal-dependent. Choice C (NG decompression + parenteral nutrition) is the standard preoperative stabilization for duodenal atresia—prevents aspiration, corrects fluid/electrolyte imbalances, allows cardiac workup. Choice A (cardiac cath) is invasive, not routine preop for AVSD. Choice B (PGE) is for ductal-dependent lesions (coarctation, critical AS/PS); AVSD is not ductal-dependent. Choice D (immediate repair) ignores need for stabilization and cardiac assessment. Choice E (endocarditis prophylaxis) is perioperative, not the primary preop management. Medical accuracy: fully consistent with neonatal surgery standards—duodenal atresia requires decompression/stabilization before repair, especially with cardiac anomalies. No logical flaws; single best answer clearly supported. Minimal fix: none needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-015", "question": "A 35-year-old woman at 20 weeks gestation with twin pregnancy develops acute shortness of breath and hemoptysis. Echocardiography shows severe mitral stenosis with pulmonary hypertension. She is hemodynamically stable. What is the most appropriate management?", "options": ["Percutaneous mitral balloon valvuloplasty", "Open mitral commissurotomy", "Therapeutic anticoagulation with heparin", "Beta-blocker therapy for rate control", "Termination of pregnancy"], "answer": "A", "answer_index": 0, "explanation": "Percutaneous valvuloplasty is preferred for severe mitral stenosis in pregnancy as it avoids cardiopulmonary bypass risks to the fetus. Open surgery is higher risk; anticoagulation prevents clots but not stenosis. Beta-blockers manage symptoms but do not address the valve. Termination is not indicated if treatable.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes a 35-year-old woman at 20 weeks gestation with twin pregnancy presenting with acute dyspnea, hemoptysis, severe mitral stenosis, and pulmonary hypertension, who is hemodynamically stable. Key discriminating findings: (1) severe symptomatic mitral stenosis in pregnancy, (2) hemodynamic stability, (3) mid-trimester gestation. The clinical problem is selecting optimal management for severe symptomatic mitral stenosis during pregnancy. Choice A (percutaneous mitral balloon valvuloplasty/PMBV) is the established treatment of choice for severe symptomatic mitral stenosis in pregnancy when medical management fails, as it definitively addresses the stenosis while avoiding cardiopulmonary bypass risks to the fetus. Choice B (open commissurotomy) requires cardiopulmonary bypass with higher fetal mortality risk. Choice C (anticoagulation) prevents thromboembolism but doesn't address the mechanical obstruction causing symptoms. Choice D (beta-blockers) provides symptomatic rate control but doesn't treat the underlying severe stenosis. Choice E (termination) is not indicated when definitive treatment is available. The keyed answer is medically accurate and represents current standard practice. No logical flaws or missing critical details prevent unique best-answer selection. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes a 35-year-old woman at 20 weeks gestation with twin pregnancy presenting with acute dyspnea, hemoptysis, severe mitral stenosis, and pulmonary hypertension, who is hemodynamically stable. Key discriminating findings: (1) severe symptomatic mitral stenosis in pregnancy, (2) hemodynamic stability, (3) mid-trimester gestation. The clinical problem is selecting optimal management for severe symptomatic mitral stenosis during pregnancy. Choice A (percutaneous mitral balloon valvuloplasty/PMBV) is the established treatment of choice for severe symptomatic mitral stenosis in pregnancy when medical management fails, as it definitively addresses the stenosis while avoiding cardiopulmonary bypass risks to the fetus. Choice B (open commissurotomy) requires cardiopulmonary bypass with higher fetal mortality risk. Choice C (anticoagulation) prevents thromboembolism but doesn't address the mechanical obstruction causing symptoms. Choice D (beta-blockers) provides symptomatic rate control but doesn't treat the underlying severe stenosis. Choice E (termination) is not indicated when definitive treatment is available. The keyed answer is medically accurate and represents current standard practice. No logical flaws or missing critical details prevent unique best-answer selection. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-016", "question": "A 29-year-old woman with polycystic ovary syndrome undergoes in vitro fertilization and develops abdominal distension, dyspnea, and oliguria 5 days post-embryo transfer. Ultrasound shows massive ascites and enlarged ovaries. Laboratory tests reveal hemoconcentration and hyponatremia. What is the most appropriate initial management?", "options": ["Intravenous albumin infusion and paracentesis", "Diuretic therapy with furosemide", "Heparin prophylaxis alone", "Expectant management at home", "Surgical ovarian detorsion"], "answer": "A", "answer_index": 0, "explanation": "Severe ovarian hyperstimulation syndrome requires fluid management with albumin for oncotic pressure and paracentesis for symptomatic relief. Diuretics worsen hypovolemia; heparin prevents thrombosis but is adjunctive. Expectant management risks deterioration; detorsion is for torsion, not OHSS.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes classic severe ovarian hyperstimulation syndrome (OHSS): young woman with PCOS post-IVF, presenting with abdominal distension, dyspnea, oliguria, massive ascites, enlarged ovaries, hemoconcentration, and hyponatremia. Key discriminating findings are the timing (5 days post-transfer), massive ascites causing respiratory compromise, and hemoconcentration indicating third-spacing with intravascular volume depletion. Option A (IV albumin + paracentesis) is the correct initial management: albumin restores oncotic pressure and intravascular volume in the setting of capillary leak, while paracentesis provides symptomatic relief from tense ascites causing dyspnea. Option B (furosemide) is contraindicated—diuretics worsen intravascular hypovolemia despite total body fluid overload. Option C (heparin alone) addresses thromboprophylaxis but ignores the acute fluid crisis. Option D (expectant home management) is dangerous given severe symptoms and risk of renal failure, thrombosis, or respiratory compromise. Option E (surgical detorsion) treats ovarian torsion, not OHSS. The item is medically accurate, logically sound, and supports a unique best answer matching the key. Minimal fix: none needed.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes classic severe ovarian hyperstimulation syndrome (OHSS): young woman with PCOS post-IVF, presenting with abdominal distension, dyspnea, oliguria, massive ascites, enlarged ovaries, hemoconcentration, and hyponatremia. Key discriminating findings are the timing (5 days post-transfer), massive ascites causing respiratory compromise, and hemoconcentration indicating third-spacing with intravascular volume depletion. Option A (IV albumin + paracentesis) is the correct initial management: albumin restores oncotic pressure and intravascular volume in the setting of capillary leak, while paracentesis provides symptomatic relief from tense ascites causing dyspnea. Option B (furosemide) is contraindicated—diuretics worsen intravascular hypovolemia despite total body fluid overload. Option C (heparin alone) addresses thromboprophylaxis but ignores the acute fluid crisis. Option D (expectant home management) is dangerous given severe symptoms and risk of renal failure, thrombosis, or respiratory compromise. Option E (surgical detorsion) treats ovarian torsion, not OHSS. The item is medically accurate, logically sound, and supports a unique best answer matching the key. Minimal fix: none needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-017", "question": "A 42-year-old woman with a history of cervical cancer treated with radiation presents with postmenopausal bleeding. Endometrial biopsy shows atypical hyperplasia. MRI reveals myometrial invasion. What is the most appropriate management considering her radiation history?", "options": ["Hysterectomy with bilateral salpingo-oophorectomy", "High-dose progestin therapy", "Repeat radiation to the pelvis", "Chemotherapy with carboplatin and paclitaxel", "Endometrial ablation"], "answer": "A", "answer_index": 0, "explanation": "Invasive endometrial cancer post-pelvic radiation requires surgical staging via hysterectomy, as further radiation risks complications like fistula. Progestins are for non-invasive hyperplasia; repeat radiation is contraindicated. Chemotherapy is adjuvant, not primary; ablation is insufficient for cancer.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 42-year-old woman with prior pelvic radiation for cervical cancer, now presenting with postmenopausal bleeding (note: 42 is premenopausal age—likely error), atypical hyperplasia on biopsy, and myometrial invasion on MRI. Key issue: the biopsy shows atypical hyperplasia (a pre-malignant condition), while MRI shows myometrial invasion (defining feature of invasive endometrial cancer). This creates internal contradiction—hyperplasia cannot invade myometrium by definition. If we assume the biopsy is correct (hyperplasia), surgery (A) is reasonable but high-dose progestin (B) is also standard for atypical hyperplasia in select cases. If we assume MRI is correct (invasive cancer), then A is clearly best, but the biopsy result contradicts this. The stem's inconsistency between pathology (gold standard) and imaging makes it impossible to determine disease stage definitively. Medical accuracy: The rationale correctly states repeat radiation is contraindicated post-pelvic RT and that surgery is standard for invasive disease, but the stem's internal contradiction undermines the item. Minimal fix: Change 'atypical hyperplasia' to 'endometrial adenocarcinoma' on biopsy to align pathology with imaging findings of myometrial invasion.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 42-year-old woman with prior pelvic radiation for cervical cancer, now presenting with postmenopausal bleeding (note: 42 is premenopausal age—likely error), atypical hyperplasia on biopsy, and myometrial invasion on MRI. Key issue: the biopsy shows atypical hyperplasia (a pre-malignant condition), while MRI shows myometrial invasion (defining feature of invasive endometrial cancer). This creates internal contradiction—hyperplasia cannot invade myometrium by definition. If we assume the biopsy is correct (hyperplasia), surgery (A) is reasonable but high-dose progestin (B) is also standard for atypical hyperplasia in select cases. If we assume MRI is correct (invasive cancer), then A is clearly best, but the biopsy result contradicts this. The stem's inconsistency between pathology (gold standard) and imaging makes it impossible to determine disease stage definitively. Medical accuracy: The rationale correctly states repeat radiation is contraindicated post-pelvic RT and that surgery is standard for invasive disease, but the stem's internal contradiction undermines the item. Minimal fix: Change 'atypical hyperplasia' to 'endometrial adenocarcinoma' on biopsy to align pathology with imaging findings of myometrial invasion.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-018", "question": "A 65-year-old man with aortic stenosis undergoes transcatheter aortic valve replacement under monitored anesthesia care. Intraoperatively, he develops complete heart block. Temporary pacing is initiated, but rhythm does not recover. What is the most appropriate long-term management?", "options": ["Permanent pacemaker implantation", "Observation for 7 days with temporary pacing", "Amiodarone infusion for rhythm control", "Dual-chamber ICD placement", "Surgical valve revision"], "answer": "A", "answer_index": 0, "explanation": "Complete heart block post-TAVR often persists due to conduction system compression, necessitating permanent pacemaker. Observation may be trialed but evidence supports early implantation if persistent. Amiodarone is not for block; ICD is for ventricular arrhythmias. Revision is for valve issues.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 65-year-old man who develops complete heart block (CHB) during TAVR that persists despite temporary pacing. Key discriminating findings: (1) CHB complicating TAVR, (2) rhythm does not recover with temporary pacing, (3) question asks for long-term management. CHB post-TAVR results from mechanical compression/injury to the conduction system (proximity of aortic annulus to AV node/His bundle). When CHB persists intraoperatively without recovery, permanent pacemaker (PPM) is indicated per ACC/AHA guidelines. Option A (PPM) is the definitive treatment for persistent high-grade AV block. Option B (observation 7 days) may be reasonable for new-onset conduction disturbances that might resolve, but the stem states rhythm \\\"does not recover,\\\" making prolonged observation inappropriate as definitive long-term management. Option C (amiodarone) treats tachyarrhythmias, not bradycardia/block. Option D (ICD) is for ventricular arrhythmia risk, not primary indication for CHB. Option E (surgical revision) addresses structural valve problems, not conduction system injury. Medical accuracy: Consistent with current TAVR management guidelines. The item correctly identifies PPM as standard care for persistent post-TAVR CHB. No fix needed; item is valid and accurate.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 65-year-old man who develops complete heart block (CHB) during TAVR that persists despite temporary pacing. Key discriminating findings: (1) CHB complicating TAVR, (2) rhythm does not recover with temporary pacing, (3) question asks for long-term management. CHB post-TAVR results from mechanical compression/injury to the conduction system (proximity of aortic annulus to AV node/His bundle). When CHB persists intraoperatively without recovery, permanent pacemaker (PPM) is indicated per ACC/AHA guidelines. Option A (PPM) is the definitive treatment for persistent high-grade AV block. Option B (observation 7 days) may be reasonable for new-onset conduction disturbances that might resolve, but the stem states rhythm \"does not recover,\" making prolonged observation inappropriate as definitive long-term management. Option C (amiodarone) treats tachyarrhythmias, not bradycardia/block. Option D (ICD) is for ventricular arrhythmia risk, not primary indication for CHB. Option E (surgical revision) addresses structural valve problems, not conduction system injury. Medical accuracy: Consistent with current TAVR management guidelines. The item correctly identifies PPM as standard care for persistent post-TAVR CHB. No fix needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-019", "question": "A 50-year-old woman with myasthenia gravis undergoes thymectomy. Postoperatively, she develops respiratory failure requiring reintubation. Acetylcholinesterase inhibitors are maximized. What is the most appropriate adjunctive therapy to facilitate extubation?", "options": ["Intravenous immunoglobulin", "Plasmapheresis", "High-dose corticosteroids", "Cyclosporine initiation", "Rituximab infusion"], "answer": "B", "answer_index": 1, "explanation": "Plasmapheresis rapidly removes autoantibodies in myasthenic crisis, aiding quicker recovery than IVIG, which is slower. Corticosteroids risk initial worsening; cyclosporine and rituximab are long-term therapies not suitable for acute crisis.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes postoperative myasthenic crisis (respiratory failure requiring reintubation after thymectomy, with maximized acetylcholinesterase inhibitors). Key discriminating findings: acute respiratory failure in myasthenia gravis patient, failure of maximal anticholinesterase therapy, need for rapid intervention to facilitate extubation. Plasmapheresis (B) is the keyed answer and represents rapid removal of pathogenic antibodies, typically showing benefit within 2-5 days. IVIG (A) is also effective but generally slower (5-7 days to peak effect). High-dose corticosteroids (C) can cause initial worsening in 30-50% of patients and take weeks for benefit. Cyclosporine (D) and rituximab (E) are maintenance immunosuppressants requiring weeks-to-months for effect, inappropriate for acute crisis. The stem clearly establishes myasthenic crisis requiring rapid intervention. While both plasmapheresis and IVIG are guideline-recommended first-line therapies for myasthenic crisis, plasmapheresis has faster onset (2-5 vs 5-7 days) and is preferred when rapid improvement is critical. The question's emphasis on 'most appropriate adjunctive therapy to facilitate extubation' supports the faster-acting option. Medical accuracy: consistent with standard myasthenic crisis management. No fix needed; item is defensible as written.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes postoperative myasthenic crisis (respiratory failure requiring reintubation after thymectomy, with maximized acetylcholinesterase inhibitors). Key discriminating findings: acute respiratory failure in myasthenia gravis patient, failure of maximal anticholinesterase therapy, need for rapid intervention to facilitate extubation. Plasmapheresis (B) is the keyed answer and represents rapid removal of pathogenic antibodies, typically showing benefit within 2-5 days. IVIG (A) is also effective but generally slower (5-7 days to peak effect). High-dose corticosteroids (C) can cause initial worsening in 30-50% of patients and take weeks for benefit. Cyclosporine (D) and rituximab (E) are maintenance immunosuppressants requiring weeks-to-months for effect, inappropriate for acute crisis. The stem clearly establishes myasthenic crisis requiring rapid intervention. While both plasmapheresis and IVIG are guideline-recommended first-line therapies for myasthenic crisis, plasmapheresis has faster onset (2-5 vs 5-7 days) and is preferred when rapid improvement is critical. The question's emphasis on 'most appropriate adjunctive therapy to facilitate extubation' supports the faster-acting option. Medical accuracy: consistent with standard myasthenic crisis management. No fix needed; item is defensible as written.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T182308874Z_grok-4-0709_seed128", "question_id": "20251216T182308874Z_grok-4-0709_seed128-020", "question": "A 60-year-old woman with bipolar disorder on lithium therapy presents with tremors, confusion, and ataxia. Serum lithium level is 2.5 mmol/L. She has acute kidney injury. What is the most appropriate management to expedite lithium clearance?", "options": ["Hemodialysis", "Forced diuresis with saline", "Gastric lavage", "Activated charcoal administration", "Discontinuation and observation"], "answer": "A", "answer_index": 0, "explanation": "Hemodialysis is indicated for severe lithium toxicity with neurologic symptoms and renal impairment, as it efficiently clears lithium. Diuresis is ineffective with AKI; lavage and charcoal do not bind lithium. Observation risks prolonged toxicity.", "generator_model": "grok-4-0709", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes severe lithium toxicity (level 2.5 mmol/L, therapeutic 0.6-1.2) with CNS manifestations (tremors, confusion, ataxia) and acute kidney injury. The question explicitly asks for management to \\\"expedite lithium clearance.\\\" Key discriminating findings: (1) severe toxicity with neurologic symptoms, (2) lithium level >2.5 mmol/L, (3) AKI preventing renal clearance. Hemodialysis (A) is the definitive treatment for severe lithium toxicity, especially with renal impairment, as lithium is a small molecule readily dialyzable. Forced diuresis (B) is ineffective with AKI and contraindicated. Gastric lavage (C) is irrelevant for chronic toxicity (patient on maintenance therapy). Activated charcoal (D) does not bind lithium. Observation (E) is dangerous given severe symptoms and impaired renal clearance. The keyed answer aligns with standard toxicology guidelines (EXTRIP criteria recommend hemodialysis for lithium >4.0 mmol/L OR >2.5 with renal failure OR severe symptoms regardless of level). Medical accuracy is excellent; the clinical scenario and management are textbook. No logical flaws or ambiguity. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes severe lithium toxicity (level 2.5 mmol/L, therapeutic 0.6-1.2) with CNS manifestations (tremors, confusion, ataxia) and acute kidney injury. The question explicitly asks for management to \"expedite lithium clearance.\" Key discriminating findings: (1) severe toxicity with neurologic symptoms, (2) lithium level >2.5 mmol/L, (3) AKI preventing renal clearance. Hemodialysis (A) is the definitive treatment for severe lithium toxicity, especially with renal impairment, as lithium is a small molecule readily dialyzable. Forced diuresis (B) is ineffective with AKI and contraindicated. Gastric lavage (C) is irrelevant for chronic toxicity (patient on maintenance therapy). Activated charcoal (D) does not bind lithium. Observation (E) is dangerous given severe symptoms and impaired renal clearance. The keyed answer aligns with standard toxicology guidelines (EXTRIP criteria recommend hemodialysis for lithium >4.0 mmol/L OR >2.5 with renal failure OR severe symptoms regardless of level). Medical accuracy is excellent; the clinical scenario and management are textbook. No logical flaws or ambiguity. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]